创伤后耐万古霉素肠球菌性眼内炎的成功治疗
Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis.
作者信息
Nguyen Jason, Hartnett Mary Elizabeth
机构信息
John A. Moran Eye Center, 65 Mario Capecchi Dr, Salt Lake City, UT, USA.
出版信息
Am J Ophthalmol Case Rep. 2017 Apr;5:117-118. doi: 10.1016/j.ajoc.2016.12.022.
PURPOSE
To highlight good visual outcome with intravitreal amikacin administered 18 days following trauma-inducing vancomycin resistant enterococcal endophthalmitis treated initially with vitrectomy and oral linezolid.
OBSERVATIONS
Despite initial vitrectomy, intravitreal vancomycin, ceftazidime and oral linezolid, smoldering vitreous infiltrates prompted treatment with intravitreal amikacin 18 days later and restored vision to 20/40 in a vancomycin-resistant traumatic endophthalmitis.
CONCLUSIONS AND IMPORTANCE
Good visual outcome was attained with intravitreal injection of amikacin 18 days following penetrating trauma and vancomycin resistant enterococcal endophthalmitis that smoldered following initial treatment of vitrectomy, intravitreal antibiotics and oral linezolid.
目的
强调在最初采用玻璃体切除术和口服利奈唑胺治疗创伤性耐万古霉素肠球菌性眼内炎18天后，玻璃体内注射阿米卡星可获得良好的视觉效果。
观察结果
尽管最初进行了玻璃体切除术、玻璃体内注射万古霉素和头孢他啶以及口服利奈唑胺，但持续存在的玻璃体浸润促使在18天后使用玻璃体内注射阿米卡星进行治疗，并使一例耐万古霉素创伤性眼内炎患者的视力恢复到20/40。
结论与意义
在穿透性创伤和耐万古霉素肠球菌性眼内炎患者中，最初采用玻璃体切除术、玻璃体内抗生素和口服利奈唑胺治疗后病情持续，在18天后玻璃体内注射阿米卡星可获得良好的视觉效果。
Zotero 插件